Literature DB >> 32127269

Anesthetic Considerations for Patients With Williams Syndrome.

Genevieve E Staudt1, Susan S Eagle2.   

Abstract

Williams syndrome (WS) is a relatively rare congenital disorder which manifests across multiple organ systems with a wide spectrum of severity. Cardiovascular anomalies are the most common and concerning manifestations of WS, with supravalvar aortic stenosis present in up to 70% of patients with WS. Although a relatively rare disease, these patients frequently require sedation or anesthesia for a variety of medical procedures. The risk of sudden death in this population is 25 to 100 times that of the general population, with many documented deaths associated with sedation or anesthesia. This increased risk coupled with a disproportionately frequent need for anesthetic care renders it prudent for the anesthesiologist to have a firm understanding of the manifestations of WS. In the following review, the authors discuss pertinent clinical characteristics of WS along with particular anesthetic considerations for the anesthesiologist caring for patients with WS presenting for non-cardiac surgery.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Williams syndrome; congenital heart disease; genetic syndrome; supravalvar aortic stenosis

Mesh:

Substances:

Year:  2020        PMID: 32127269     DOI: 10.1053/j.jvca.2020.01.022

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  2 in total

Review 1.  Williams syndrome.

Authors:  Beth A Kozel; Boaz Barak; Chong Ae Kim; Carolyn B Mervis; Lucy R Osborne; Melanie Porter; Barbara R Pober
Journal:  Nat Rev Dis Primers       Date:  2021-06-17       Impact factor: 65.038

2.  Left Ventricular Outflow Tract Gradient Is Associated With Coronary Artery Obstruction in Children With Williams-Beuren Syndrome.

Authors:  Angela Yun June Tan; Daniel Quiat; Sunil J Ghelani; Koichi Yuki
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-01-04       Impact factor: 2.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.